Research article · 15 Jan 2017
Conference abstractPublished 19 Dec 2014
Up-regulation of Nur77 by HDAC inhibitors is important for neurite outgrowth
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Histone deacetylase (HDAC) inhibitors can induce neuronal differentiation. The effect of HDAC inhibitors is not limited to neuronal differentiation but to cell survival. We have reported that treatment with HDAC inhibitors promotes neurite outgrowth and cell survival via expression of nerve growth factor IB (Nur77), one of the immediate early genes (IEG), in rat PC12 cells. While Nur77 leads to expression of a family of proteins, including Nor1, the function of Nor1 following HDAC inhibitor treatment remains unclear. Thus, we analyzed whether Nor1 is an essential gene product for neurite out growth in response to HDAC inhibitors, compared with the expression of Nur77 in response to forskolin (FSK), because FSK is known to induce neurite outgrowth. We used HDAC inhibitors (trichostatin A (TSA) or K-350) and FSK as a positive control for neurite outgrowth. We also added siRNA to deplete the expression of Nur77. The neurites were photographed using phase-contrast microscopy and the length of each neurite was measured using analysis software. We found that TSA and K-350 both induced neurite outgrowth accompanied with expression of Nur77 after treatment of the cells for 24 hours. We also observed that only FSK induced the expression of Nor1. Furthermore, siRNA against mRNA for Nur77 prevented the TSA-induced neurite outgrowth. These results suggest that while the expression of Nor1 is not essential, the expression of Nur77 is necessary for neurite outgrowth by HDAC inhibitors.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2012
New Orally Bioavailable 2-aminobenzamide-type Histone Deacetyase Inhibitor Promotes Neurite Outgrowth via histone H3 Modification in PC12 cells: a Possible Therapeutic Candidate for Neuronal Diseases
Editorial · 2016
Epigenetic Regulation: Neurite Outgrowth by Hormonal or Chemical Mechanisms in PC12 Cells
Review article · 4 Mar 2013
Histone Deacetylase Inhibitor for Neurodegenerative Diseases: A Possible Medicinal Strategy by Prevention of ER Stress-Mediated Apoptosis and Induction of Neurite Elongation
Research article · 16 Oct 2023
Molecular Docking, Synthesis and Preliminary Evaluation of Hybrid Molecules of Benzothiazole Cross-Linked with Hydroxamic Acid by Certain Linkers as HDAC Inhibitors
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Research article · 27 Jul 2026
Qualitative LC/MS Assessment of Fenfluramine Hydrochloride After Dilution in Purified Water : A Preliminary Study and Case Report
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Koji Shimoke”
- BylineArticles whose byline prints “Takuma Tomioka”
- BylineArticles whose byline prints “Hiroki Maruoka”
- BylineArticles whose byline prints “Toshihiko Ikeuchi”
